Status:
COMPLETED
Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad
Lead Sponsor:
Shaheed Zulfiqar Ali Bhutto Medical University
Conditions:
Status Epilepticus
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Status epilepticus is the second most common neurologic emergency in children. Morbidity and mortality are considerable; thus, timely termination of convulsive status epilepticus is the primary goal o...
Detailed Description
OPERATIONAL DEFINITION Status Epilepticus: It is defined as continuous seizure activity or recurrent seizure activity without regaining of consciousness lasting for more than 5 minutes. Efficacy: ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Children with status Epilepticus i.e with continuous seizure of 5 min or more or two or more discrete seizures in which there is incomplete recovery of consciousness was included in this study.
- Convulsive states epilepticus,
- Generalized tonic clonic seizures,
- Focal tonic clonic seizures are included.
- Age:6 months to 12 years.
- Gender: Both genders.
- Exclusion Criteria:
- Participants on any antiepileptic drug (AED) or having allergic reaction towards phenytoin or Levetiracetam were excluded from the study.
- Non convulsive status epilepticus,
- Absence status epilepticus,
- Myoclonic status epilepticus were excluded.
Exclusion
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06067412
Start Date
August 1 2022
End Date
January 31 2023
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hopsital Faisalabad
Faisalābad, Punjab Province, Pakistan